142 related articles for article (PubMed ID: 6420108)
21. Renal failure as the presenting feature of light chain myeloma of kappa type.
Raina V; Veluchamy K; Kumar R; Malaviya AN
J Assoc Physicians India; 1982 Sep; 30(9):636-8. PubMed ID: 6820955
[No Abstract] [Full Text] [Related]
22. [Non-amyloid nephrotic syndrome: first isolated manifestation of a kappa light chain myeloma (author's transl)].
Mignon F; Vasmant D; Richet G; Wang A; Morel-Maroger L; Brouet JC
Ann Med Interne (Paris); 1979; 130(11):513-6. PubMed ID: 121516
[TBL] [Abstract][Full Text] [Related]
23. Relevance of class, molecular weight and isoelectric point in predicting human light chain amyloidogenicity.
Bellotti V; Merlini G; Bucciarelli E; Perfetti V; Quaglini S; Ascari E
Br J Haematol; 1990 Jan; 74(1):65-9. PubMed ID: 2106912
[TBL] [Abstract][Full Text] [Related]
24. Light chain cardiomyopathy. Structural analysis of the light chain tissue deposits.
Gallo G; Goñi F; Boctor F; Vidal R; Kumar A; Stevens FJ; Frangione B; Ghiso J
Am J Pathol; 1996 May; 148(5):1397-406. PubMed ID: 8623912
[TBL] [Abstract][Full Text] [Related]
25. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
[TBL] [Abstract][Full Text] [Related]
26. Tubular function in multiple myeloma.
Coward RA; Mallick NP; Delamore IW
Clin Nephrol; 1985 Oct; 24(4):180-5. PubMed ID: 3933870
[TBL] [Abstract][Full Text] [Related]
27. Light chain deposition nephropathy in multiple myeloma.
Comotti C; Mazzon M; Valli A; Rovati C; Vivaldi P
Contrib Nephrol; 1993; 105():133-8. PubMed ID: 8252859
[No Abstract] [Full Text] [Related]
28. High incidence of intact or fragmented immunoglobulin in urine of patients with multiple myeloma.
Kraj M; Kruk B; Lech-Marańda E; Warzocha K; Prochorec-Sobieszek M
Leuk Lymphoma; 2015; 56(12):3348-56. PubMed ID: 25860239
[TBL] [Abstract][Full Text] [Related]
29. Light chain multiple myeloma in a patient with long-standing rheumatoid arthritis.
Alexopoulou A; Dourakis SP; Apostolopoulou A; Kandyli A; Pandelidaki H; Archimandritis AJ
Clin Rheumatol; 2005 Nov; 24(6):669-70. PubMed ID: 15856363
[No Abstract] [Full Text] [Related]
30. [Quantitation of the urinary L-chain multiple myeloma (author's transl)].
Tominaga K
Rinsho Byori; 1976 Apr; 24(4):294. PubMed ID: 819682
[No Abstract] [Full Text] [Related]
31. Glomerular and tubular handling of differently charged human immunoglobulin light chains by the rat kidney.
Baylis C; Falconer-Smith J; Ross B
Clin Sci (Lond); 1988 Jun; 74(6):639-44. PubMed ID: 3135143
[TBL] [Abstract][Full Text] [Related]
32. Urinary free light chain analysis by the Freelite immunoassay: a preliminary study in multiple myeloma.
Le Bricon T; Bengoufa D; Benlakehal M; Bousquet B; Erlich D
Clin Biochem; 2002 Oct; 35(7):565-7. PubMed ID: 12493586
[TBL] [Abstract][Full Text] [Related]
33. Myeloma light chains are ligands for cubilin (gp280).
Batuman V; Verroust PJ; Navar GL; Kaysen JH; Goda FO; Campbell WC; Simon E; Pontillon F; Lyles M; Bruno J; Hammond TG
Am J Physiol; 1998 Aug; 275(2):F246-54. PubMed ID: 9691015
[TBL] [Abstract][Full Text] [Related]
34. Immunoglobulin light-chain immunoblots of urine proteins from patients with tubular and Bence-Jones proteinuria.
Norden AG; Fulcher LM; Flynn FV
Clin Chim Acta; 1987 Jul; 166(2-3):307-15. PubMed ID: 3113774
[TBL] [Abstract][Full Text] [Related]
35. Multiple narrow bands in urine protein electrophoresis.
Roach BM; Meinke JS; Sridhar N; Vladutiu AO
Clin Chem; 1999 May; 45(5):716-8. PubMed ID: 10222367
[No Abstract] [Full Text] [Related]
36. [Analysis of monoclonal protein in 72 cases of multiple myeloma].
Yang JJ; Zhang GS; Chen XR
Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):152-4. PubMed ID: 12536652
[TBL] [Abstract][Full Text] [Related]
37. Light Chain Cast Nephropathy: Practical Considerations in the Management of Myeloma Kidney-What We Know and What the Future May Hold.
Manohar S; Nasr SH; Leung N
Curr Hematol Malig Rep; 2018 Jun; 13(3):220-226. PubMed ID: 29725932
[TBL] [Abstract][Full Text] [Related]
38. Light-chain nephropathy.
Fang LS
Kidney Int; 1985 Mar; 27(3):582-92. PubMed ID: 3923250
[No Abstract] [Full Text] [Related]
39. [Urinary N-acetyl-beta-D-glucosaminidase and gamma-glutamyl-transpeptidase activities for evaluation of renal disturbance in patients with multiple myeloma].
Nishimura K; Kawada M; Suehiro T; Yamano T; Hashimoto K
Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1087-94. PubMed ID: 1363243
[TBL] [Abstract][Full Text] [Related]
40. Screening and differential diagnosis of renal light chain-associated diseases.
Gerth J; Sachse A; Busch M; Illner N; Muegge LO; Gröne HJ; Wolf G
Kidney Blood Press Res; 2012; 35(2):120-8. PubMed ID: 22056791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
